Table 1.
Patient CSF sample data sheet giving PMI and diagnosis information
| Sample ID | Race (1 = white) | Gender (M/F) | Expired age | PMI | DX summary |
|---|---|---|---|---|---|
| ND1 | 1 | M | 71 | 3 | Control brain showing only very mild normal aging changes |
| ND2 | 1 | M | 80 | 2.4 | Control brain showing only mild, normal age-related changes |
| ND3 | 1 | M | 65 | 3.5 | Brain within normal limits for age (control brain); Alzheimer type II astrocytosis |
| AD1 | 1 | F | 82 | 4 | Alzheimer’s disease (AD); microscopic foci (2), cerebellar cortical sclerosis |
| AD2 | 1 | F | 57 | 2.16 | Alzheimer’s disease, presenilin 1 gene mutation (AD); Cerebral white matter rarefaction |
| AD3 | 1 | F | 84 | 1.83 | Alzheimer’s disease (AD); Cerebral white matter rarefaction; Etat crible, basal ganglia; Old infarct, right cerebellar hemisphere |
| PD1 | 1 | M | 80 | 2 | Parkinson’s disease (PD); non-diagnostic Alzheimer’s changes |
| PD2 | 1 | M | 70 | 1.83 | Parkinson Disease (PD); Dementia (history) |
| MSA | 1 | M | 83 | 2.16 | Parkinson’s disease (PD); dementia (history); Shy-Drager syndrome (autonomic failure) |
Generously provided by Dr Thomas Beach (Civin Laboratory for Neuropathology, Banner/Sun Health Research Institute, Sun City, AZ).